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Abstract
Introduction: Since its independence in 2002, Timor Leste has made significant strides in 
improving childhood vaccination coverage. However, coverage is still below national targets, and 
children continue to have missed opportunities for vaccination (MOV), when eligible children 
have contact with the health system but are not vaccinated. Timor Leste implemented the updated 
World Health Organization methodology for assessing MOV in 2016.
Methods: The MOV data collection included quantitative (caregiver exit interviews and health 
worker knowledge, attitudes, practices surveys (KAP)) and qualitative arms (focus group 
discussions (FGDs) with caregivers and health workers and in-depth interviews (IDIs) with health 
administrators). During a four-day period, health workers and caregivers with children <24 months 
of age attending the selected eight facilities in Dili Municipality were invited to participate. The 
researchers calculated the proportion of MOV and timeliness of vaccine doses among children 
with documented vaccination histories (i.e., from a home-based record or facility register) and 
thematically analyzed the qualitative data.
Results: Researchers conducted 365 caregiver exit interviews, 169 health worker KAP surveys, 4 
FGDs with caregivers, 2 FGDs with health workers, and 2 IDIs with health administrators. Among 
eligible children with documented vaccination histories (n = 199), 41% missed an opportunity for 
vaccination. One-third of health workers (33%) believed their knowledge of immunization 
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practices to be insufficient. Qualitative results showed vaccines were not available at all selected 
health facilities, and some facilities reported problems with their cold chain equipment.
Conclusion: This study demonstrates that many children in Timor Leste miss opportunities for 
vaccination during health service encounters. Potential interventions to reduce MOV include 
training of health workers, improving availability of vaccines at more health facilities, and 
replacing unusable cold chain equipment. Timor Leste should continue to scale up successful 
MOV interventions beyond Dili Municipality to improve vaccination coverage nationally and 
strengthen the health system overall.
Keywords
Missed opportunities for vaccination; Immunization; Vaccination coverage; Coverage and equity; 
Healthcare utilization; Timor Leste
1. Introduction
Timor Leste is a small country on the eastern half of the island of Timor and is one of the 
world’s newest nations, having gained independence in 2002. It has a population of almost 
1.3 million, of which 60% are younger than 25 years [1]. Dili municipality, which is the 
national capital, is one of 13 municipalities in Timor Leste. Dili is the smallest municipality 
in Timor Leste in terms of geographic area, but has a population of 281,000, comprising 
more than 20% of the total population of Timor Leste [1]. Tetun and Portuguese are the 
official languages of Timor Leste; about 32 indigenous languages are also spoken [1].
A civil war between 1975 and 1999 caused extensive damage to Timor Leste’s health 
infrastructure with more than 30% of health facilities completely destroyed [2–4]. By the 
end of the civil war, nearly all medical equipment had been damaged beyond use and only 
about 25 doctors remained in the country [2]. Immediate efforts were made in the early 
2000s to rebuild the health infrastructure. Within two years of the end of the conflict, the 
number of health workers in the country increased to 800, and the country now has more 
than 1000 doctors, one national hospital (Hospital Nacional Guido Valadares [HNGV]), 5 
referral hospitals, and more than 70 community health centers (CHCs) and 300 health posts 
[5–8].
Since gaining its independence in 2002, the government has prioritized childhood 
immunization [1]. Coverage of the third dose of diphtheria-tetanus-pertussis vaccine (DTP) 
increased from 63% in 2006 to 92% in 2017, based on official estimates and from 63% to 
76% during that same time period according to World Health Organization (WHO) and 
United Nations Children’s Fund (UNICEF) estimates of national immunization coverage 
(WUENIC) [9]. Gavi, the Vaccine Alliance (Gavi) began supporting Timor Leste in 2012, 
following a request for financial assistance in 2011 for introduction of DTP-hepatitis B-
Haemophilus influenzae type b vaccine (pentavalent) and in 2013 for Health Systems 
Strengthening (HSS) support. In 2015, Timor Leste became the final country in the 
Southeast Asia Region to establish a National Immunization Technical Advisory Group [10]. 
To further improve its immunization program, Timor Leste began a two-year “twinning” 
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program with Sri Lanka in 2017 to learn from the Sri Lanka immunization program, which 
has one of the best immunization coverage rates in Southeast Asia [11,12].
Despite big improvements in immunization coverage over the past several years, children are 
still being missed for vaccinations during health center visits. In a secondary data analysis 
performed in 2016, about half (47%) of children in Timor Leste were not fully immunized, 
with a third of all children (30–40%) having a missed opportunity for vaccination (MOV) 
[13]. A MOV includes any contact with health services by a child (or adult) who is eligible 
for vaccination (unvaccinated, partially vaccinated/not-up-to-date, and free of 
contraindications) where they do not receive all the vaccine doses for which he or she is 
eligible [14–16]. In the first systematic literature review of MOV, the global median MOV 
prevalence was 32% among both children and women of childbearing age who visited a 
health center and 67% among the subpopulation of women and children eligible for 
vaccination at the time of visit [15]. In an updated systematic review published in 2014, the 
global median MOV prevalence remained at 32% among children and 47% among women 
of childbearing age who visited a health center [17].
In May 2016, Timor Leste was selected as the first country in the Southeast Asia Region to 
pilot the WHO methodology for assessment of MOV [18]. The main objective was to 
identify potential areas of improvement to reduce MOV and further improve coverage and 
equity by identifying and characterizing the extent of MOV among children <24 months of 
age attending health services.
2. Methods
2.1. Study design
The assessment of MOV in Timor Leste utilized a cross-sectional study design employing 
both qualitative and quantitative methods based on the WHO Planning Guide to Reduce 
Missed Opportunities for Vaccination (MOV) and Methodology for the Assessment of 
Missed Opportunities for Vaccination [16,18]. Past MOV assessments and the MOV guides 
describe the detailed process of the MOV assess ment [16,18–21]. The methodology, as 
implemented in Timor Leste, is described below.
Quantitative data collection included health center exit interviews (with caregivers) and 
knowledge, attitudes, and practices (KAP) surveys (with health workers). Qualitative data 
collection involved focus group discussions (FGDs) with caregivers, FGDs with health 
workers and in-depth interviews (IDIs) with health center administrators. The assessment 
concluded with a brainstorming session of interventions to reduce MOV and a high-level 
debrief and endorsement of an MOV intervention work plan.
2.2. Data collection tools
The generic WHO MOV caregiver exit questionnaire, health worker KAP survey, and FGD 
and IDI guides were adapted for use in Timor Leste and translated into the local language 
(Tetun)[18]. Caregiver exit questionnaires collected information on the demographics of the 
child and caregiver, the reported reason for the visit, the child’s vaccination history, and the 
caregiver’s knowledge of routine immunization. The health worker KAP surveys included 
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participant demographics and health worker knowledge of vaccination and attitudes toward 
vaccination, with an additional section on vaccination practices targeted specifically at 
health workers who routinely administer vaccines. The caregiver exit questionnaires and 
KAP surveys included both mandatory and non-mandatory questions. FGD and IDI guides 
focused on understanding why opportunities for vaccination were missed and what could be 
done to address any problem areas.
2.3. Sampling
Dili Municipality was chosen as the MOV assessment area because it comprises more than 
20% of the country’s total population and because of operational and logistical difficulties in 
reaching other municipalities [1]. As suggested in the MOV methodology, efforts were made 
to include both urban and rural settings and public and private facilities. The HNGV, five 
CHCs (Bairo Formosa, Becora, Comoro, Metinaro, Veira Cruz), and two private or 
nongovernmental organization (NGO) clinics (Bairo Pite and Hospital Maternidade 
Fatumenta) were selected for data collection. Initially, data collection was planned in all six 
of the CHCs in Dili Municipality, but the local MOV strategy team deemed the sixth CHC, 
located on the small island of Atauro, inaccessible due to transportation constraints. As a 
result, only one health facility included in the sample (CHC Metinaro) is considered rural, 
while the rest are considered urban facilities. In Timor Leste, private or NGO facilities also 
provide vaccination free of charge; however, they account for less than 1% of all vaccination 
in the country. Because private clinics are unique to Dili Municipality (as they are not found 
elsewhere in the country), and account for a high proportion of patient flow in Dili, they 
were also included in the sampling. Private or NGO facilities were purposely selected based 
on clinic size.
In Timor Leste, all 70 CHCs and all five referral hospitals have access to electricity and cold 
chain equipment and provide daily vaccination services [8]. Due to a policy requirement, the 
HNGV only provides vaccines to newborns. Each CHC serves 8–13 sucos (villages). Some 
sucos have health posts while others do not. There are over 300 health posts in the country 
[8]. A proportion of these health posts also provide daily vaccination services. For the sucos 
without health posts, Integrated Community Health Services (SISCa) are conducted monthly 
by the associated CHC. All the selected CHCs, health posts, private, and NGO health 
facilities for the MOV assessment offer daily vaccination services.
2.4. Data collection
Prior to data collection, 11 quantitative data collectors underwent three days of training in 
Dili on the MOV methodology and use of tablets for electronic data collection. All 
quantitative data were collected on tablets using survey software (Zegeba AS [Alesund, 
Norway]). Two qualitative data collectors also participated in the training, with a separate 
half-day training to familiarize them with the qualitative data collection methodology and 
the facilitation guides.
Data collection took place during May 16–19, 2016. On the first two days, six data 
collectors visited their assigned CHCs and, on the third day, visited a convenience sample of 
health posts associated with the assigned CHCs. The remaining data collectors were 
Li et al. Page 4
Vaccine. Author manuscript; available in PMC 2019 August 13.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
assigned to the HNGV and private clinics. The two qualitative data collectors covered all the 
health facilities included in the sample.
All tablets and survey forms were password-protected. Only the assessment coordinator had 
access to all the surveys. Quantitative data were routinely uploaded and backed up to a 
secure network. Paper notes were destroyed once backed up electronically. Qualitative data 
notes were recorded on paper and later typed up for analysis.
2.5. Study population
The primary unit of analysis was children <24 months. Care-givers who were accompanied 
by a child who appeared to be <24 months of age were approached as they were exiting 
health facilities and requested to participate in a survey. If a caregiver was accompanied by 
more than one eligible child, questions were asked about the youngest child. Researchers 
abstracted only vaccination dates recorded in the official or temporary mother and child 
home-based record booklet/Livrinho Saúde Inan ho Oan (LISIO) or in the health center’s 
vaccination registers. No verbal reports of vaccination status or vaccination dates were 
accepted. All health center staff members were invited to participate in a self-administered 
KAP survey, independent of the department in which they routinely work. Although all 
health professionals (nurses, midwives and doctors) are competent to provide immunization 
services, the majority of EPI focal points in Timor Leste health facilities are nurses or 
midwives. Each team of data collectors aimed to complete a total of 50 exit interviews and 
25 health worker KAP surveys over the four days of data collection. Caregiver exit 
interviews lasted approximately 20 min, while KAP surveys took 15 to 30 min to complete. 
All quantitative data were collected in Tetun.
For the FGDs, caregivers and health workers were selected from the same health facilities 
identified for quantitative data collection (excluding health posts). To reduce bias, FGDs 
were conducted on a different day, and participants in the quantitative arm were excluded 
from the qualitative interviews. Caregivers who were accompanied by a child who appeared 
to be <24 months of age were requested to participate as they were exiting the health center; 
age was then verified as reported by the caregiver. Caregivers were approached until the 
target of 4–6 participants per FGD session was reached. All health workers working at the 
selected health center on the day of qualitative data collection were also invited to participate 
in the health worker FGD, regardless of their involvement in vaccination services. Key 
informants for IDIs were identified among health administrators at selected health centers. 
FGDs were moderated and IDIs conducted in English using an English-Tetun interpreter. 
The qualitative team aimed to conduct one caregiver FGD, one health worker FGD, and two 
key informant IDIs at each health facility.
2.6. Data analysis
All quantitative data were extracted in Excel format from the electronic data collection 
platform and analyzed using Stata (version 14.2, College Station, Texas). The researchers 
created an eligibility tree to determine the total number of children with documented 
vaccination dates, those due at least one vaccine dose, and those with at least one MOV [15]. 
Frequency distributions were created for each variable from the caregiver exit interviews 
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(among children with documented vaccination dates or documented evidence of non-
vaccination) and the health worker KAPs. The final number of children with documented 
vaccination dates was determined from two sources, either the LISIO or the health facility 
register. Analyses using vaccination dates excluded children with illegible or invalid dates 
(either recorded incorrectly in the LISIO or facility register or on the questionnaire by the 
data collector).
Researchers then assessed MOV based on the child’s age on the date of interview, eligibility 
for vaccines in the national schedule, and contraindications (as reported by the caregiver). 
MOV were calculated among children who were eligible for at least one vaccine dose 
without valid contraindications, as per the national policy. The MOV estimate is a 
measurement of the inefficiencies of the health service in immunizing all eligible children 
[15]. Next, MOV was stratified by reason for visit and by vaccine type. All vaccines in the 
national schedule, with the exception of hepatitis B birth dose, inactivated polio vaccine 
(IPV), second dose of measles and rubella (MR2) vaccine, and one booster dose of DTP 
vaccine, were included in the calculation of MOV. These vaccines were excluded because 
they had only recently been introduced in Timor Leste and were not yet widely available at 
the time of data collection.
Researchers used the documented birth and vaccination dates to assess timeliness of 
vaccination. Extrapolating from past timeliness studies and using the nationally 
recommended ages for vaccination in Timor Leste, intervals for early, timely, and late 
vaccination were created for each of the vaccines in the national schedule, with the 
exception of recently introduced vaccines (hepatitis B birth dose, IPV, MR2, and one booster 
dose of DTP vaccine). Grace periods for the timely and late categories were included (Table 
1) [22,23]. Intervals for administering all antigens, with the exception of bacille Calmette-
Guerin (BCG) vaccine and oral polio vaccine (OPV) birth dose, do not have upper age limits 
in line with the national policy. BCG and OPV birth dose do have upper age limits per the 
national policy to not administer these vaccines after 365 days.
Researchers conducted a thematic analysis of the qualitative data and the comments fields of 
the quantitative surveys. The qualitative study team extracted key themes through an 
iterative process of re-readings of the notes from the FGDs, IDIs, and comments fields. Final 
themes were determined by consensus of the MOV assessment team.
2.7. Ethical approval
The Timor Leste Ministry of Health (MoH) Human Research Ethics Committee, reviewed 
all the study documents and considered the study protocol to be exempt as it was a program 
assessment. The study team included a verbal consent procedure before administering 
surveys or conducting FGDs or IDIs to ensure that participants had the opportunity to 
understand the assessment procedure and to decline participation. They were informed that 
participation was voluntary, they could leave the assessment at any time, and could choose to 
not answer any questions without repercussion. As there was no personally identifiable 
information collected, the Human Research Ethics Committee considered verbal consent to 
be appropriate as participation posed minimal risk to the participants. All participants in 
FGDs and IDIs also gave verbal consent for their direct quotes to be used in a manuscript.
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3. Results
During four days of data collection, 11 data collectors completed 365 caregiver exit 
interviews (Fig. 1, Table 2) and 169 health worker KAPs at eight health centers. Data 
collectors completed a median of 50 caregiver surveys per health center and its associated 
health post (range: 10–67) and a median of 21 health worker KAPs per health center (range: 
9–38) (data not shown in tables). There were no refusals to participate in the survey.
Due to logistical difficulties, the qualitative team only conducted four FGDs with caregivers, 
two FGDs with health workers, and two IDIs with health center administrators.
3.1. Caregiver interviews and FGDs
3.1.1. Demographics—Of the 365 caregiver interviews conducted, 286 (78%) of the 
children had a documented vaccination date either recorded in the official or temporary 
LISIO or in the health center’s vaccination registers (Fig. 1); <5 were excluded because of 
illegible or invalid documented dates (data not shown). Approximately three-quarters (n = 
218) of the interviews among caregivers with children aged <24 months and with 
documented vaccination dates were conducted in the five public CHCs and the HNGV, and 
the remaining (n = 68) were conducted in the two private facilities (Table 2). The majority of 
caregivers interviewed were mothers (93%), and most had some education (92%).
3.1.2. Vaccination and caregiver attitudes—More than half of the children with 
documented vaccination dates were at the health center for a vaccination visit (164/286; 
57%), and 87% had their LISIO in their possession at the visit (Tables 2 and 3). Among 
caregivers who did not have their LISIO, one indicated that they “never bring [LISIO] if not 
visiting for vaccination and growth monitoring.” (Exit interview, comments field) Among 
those whose children were vaccinated during the visit, most (92%) stated that they were 
informed of their child’s next vaccination appointment date. A caregiver during a FGD said, 
“The health workers always explain when the next doses are due.” How ever, only one-
quarter (25%) of caregivers were told about potential adverse events following immunization 
(AEFI). In general, caregivers had positive attitudes toward vaccination and believed that 
vaccination was beneficial: “Vaccines are always available. We need to take our children,” 
said one caregiver during a FGD, and another stated, “Vaccination is good… not cause any 
disease.”
When caregivers were asked how the health center could improve, 29% cited the desire for 
better information on the vaccines administered, the diseases that the vaccines protected 
against, and AEFI: “… mothers don’t understand about the immunization.” (Exit interview, 
comments field) Additionally, mothers discussed how they feared AEFI, particularly 
because they felt as though some health workers were not well-trained enough to respond to 
adverse events, and “husbands complain of fever and AEFI.” (Care-giver FGD) Caregivers 
also cited the need for expanded and more flexible vaccination hours and days (14%), with 
some mothers asking for more home visits and regular outreaches: “…ensure nurses/
midwives go to the SISCa to find and track defaulters and announce outreach days ahead, so 
mothers are ready.” (Caregiver FGD) One-quarter of the exit interview respondents 
suggested making more personnel available (27%) and reducing wait times (26%) as a way 
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to improve services (Table 2), with 9% of respondents indicating both (data not shown). This 
sentiment was also echoed in caregiver FGDs: “Reduce the long wait!” (Caregiver FGD) 
The qualitative data showed some complaints about the waiting room facilities: “The waiting 
room for vaccination is not so good, waiting under sunshine and just call through window.” 
(Exit interview, comments field) Caregivers would like an improvement in health worker 
attitudes, as some caregivers are discouraged by their demeanor: “If mothers give birth at 
home, health workers get mad and refuse to vaccinate, which leads to delays.” (Caregiver 
FGD) Caregivers also cited some preferential treatment: “We are not satisfied. [Health 
workers] are unfair to those without a relative in the CHC.” (Caregiver FGD)
3.1.3. Missed opportunities for vaccination (MOV)—Among all children with 
documented vaccination dates, 70% (199/286) were eligible for one or more vaccine doses 
during their health center visit (Fig. 1; Table 3). Some caregivers reported perceived 
contraindications which included a cough and/or cold, diarrhea, and malnutrition or anemia 
(data not shown), but no children were excluded from the analysis as a result of a reported 
valid contraindication (Fig. 1). Eighty-two percent (235/286) of children with documented 
vaccination dates had their dates recorded from their LISIO (data not shown). The remaining 
18% (51/286) were documented either from the health facility register (36/286) or the source 
was not recorded in the questionnaire (15/286) (data not shown). During the visit, 118 of the 
199 eligible children were vaccinated with all eligible doses, leaving 81 eligible children 
unvaccinated or under-vaccinated because of MOV. Therefore, among the children who were 
not up-to-date prior to the visit and were eligible for at least one vaccine dose, 41% (81/199) 
had a MOV (Fig. 1, Table 3). Among those at the health center for a vaccination visit, 32% 
(48/151) had a MOV, compared with 69% (33/48) of those attending the health service for a 
non-vaccination visit (Table 3).
Among children eligible for vaccination at their visit, 353 doses were due, of which 31% 
were missed (108/353) (Table 4). The largest percentage of missed doses were for OPV birth 
dose and measles and rubella vaccine first dose (MR1), with 65% (31/48) and 51% (21/41) 
of doses missed, respectively.
3.1.4. Timeliness—Timeliness of vaccine doses among children with documented 
vaccination history varied by vaccine and dose, with timely administration of vaccines 
ranging from 64% to 90% (Table 4). Vaccine doses that were recommended later in the 
series were given in a less timely manner; for instance, timeliness of pentavalent vaccine fell 
from 77% for the first dose to 65% for the third dose. Nonetheless, MR1, given optimally at 
nine months, was given in a timely manner 90% of the time (36/40).
3.2. Health worker interviews, FGDs, and IDIs
3.2.1. Demographics—Health workers participating in the KAP surveys included 
clinicians, nurses, midwives, and nursing assistants; the majority were nurses or midwives 
(65%) (Table 5). Of participating health workers, 43% had four years or fewer of clinical 
experience, whereas 19% had more than 20 years of experience. About half (45%) had 
previously been trained in vaccination or vaccine-preventable diseases, and 56% stated that 
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their health center had opportunities for clinical or academic training sessions as part of 
continuing education.
3.2.2. Knowledge, attitudes, and practices—One-third (33%) of the health workers 
believed their knowledge of vaccination to be insufficient. This was echoed during the FGDs 
and IDIs, where health workers cited being particularly unfamiliar with protocols regarding 
delayed vaccinations. Health workers also expressed confusion about the national guidance 
on “over-aged” children (children beyond recommended ages for vaccination, but who have 
not yet received any previous vaccinations or have delayed doses): “We need training on 
immunization.” (Health worker KAP, comments field) Trainings should also expand beyond 
Expanded Programme on Immunization (EPI) staff: “The nurses in health posts also need 
training on vaccination,” “As doctors we need training on vaccination,” and “The 
government people get sufficient training; private clinic [staff] do not.” (Health worker KAP, 
comments field) Health workers also expressed the need for training when new vaccines are 
introduced: “If there is a new vaccine, need to brief all health staff, and the new vaccine 
must [be] announced through media.” (Health worker KAP, comments field)
Additionally, 40% of health workers said they feared AEFI (Table 5). When asked about 
valid contraindications to vaccination, only 24% were able to identify pneumonia and other 
serious diseases from a multiple choice, multi-select list of options (which also included 
local reaction to a previous dose, low-grade fever, and seizures under medical treatment).
About half (46%) of all participating health workers reported that completing vaccination 
registers delayed delivery of vaccines (Table 5). During FGDs, health workers also discussed 
the need for improving the current recording and tracking systems, particularly for follow-up 
across health facilities: “Encourage better reporting by the district head office to centralized 
data.” (Health worker FGD) There was also a call for inclusion of all health facilities in the 
reporting systems, especially private health facilities: “In Dili, private clinics do not report to 
the CHC/district [level].” (Health worker FGD)
Forty-two health workers’ regular duties included administering vaccines (Table 5). The 
majority of health workers whose regular duties include administering vaccines believed that 
the health center was adequately staffed for immunization (86%, 36/42) and had enough 
vaccine vials for all patients in need (93%, 39/42). However, qualitative data collection 
revealed that vaccines were not available at all the facilities that were sampled. For example, 
only newborn vaccines are available at the HNGV due to a policy requirement. Caregivers 
expressed their desire for the HNGV to offer all vaccination services on a regular basis: “If 
possible, have vaccines in hospital too.” (Exit interview, comments field) Because vaccines 
are not available, caregivers have to make other arrangements for their infants to receive 
vaccinations: “We always get vaccines in CHC, because there are no vaccines in hospital.” 
(Exit interview, comments field) Additionally, vaccines were not available at one health 
facility because of nonfunctional cold chain equipment: “No vaccination in this clinic! If we 
had the vaccines, we’d give it, even to accompanying children… we need adequate 
storage… fridge seal is broken.” (Key informant IDI) Furthermore, health workers were 
somewhat hesitant to open vials for only one child: “Because only one baby, they could not 
provide the BCG vaccination to the baby.” (Exit interview, comments field)
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4. Discussion
Timor Leste was the first country in the Southeast Asia Region to implement the updated 
WHO MOV methodology and the third country globally, following Chad and Malawi [21]. 
In addition to being the youngest country in the region, Timor Leste was selected to carry 
out this MOV assessment because it was considered a lower-performing country in the 
Southeast Asia Region. Through this assessment, researchers found that 41% of eligible 
children had a MOV during the health services encounter. Through the collection of both 
quantitative and qualitative data, researchers were able to identify areas of focus for 
improving the health system, including measures for increasing caregiver knowledge; 
strategies for improving health worker KAPs related to eligibility, contraindications, and 
management of AEFI; and systems changes so that vaccine and vaccination-related supplies 
are available and functioning and immunization status checks are done routinely.
Strategic investments in both caregiver and health worker education are needed. Among 
caregivers, the researchers documented their lack of understanding of which vaccines were 
included in the national schedule. Caregivers repeatedly cited the desire for increased 
education in this area. Improving health promotion in health facilities and communities is 
critical for addressing care-givers’ poor understanding related to immunization issues. 
Limited knowledge was also echoed in the health worker KAPs and qualitative research. 
Health workers reported knowledge gaps on national immunization policies and guidelines, 
especially regarding delayed vaccination, whether or not and when to open multi-dose vials. 
They also reported being unfamiliar with newly introduced vaccines; in 2016, Timor Leste 
introduced hepatitis B birth dose, IPV, measles and rubella vaccine, and one booster dose of 
DTP vaccine. Both caregivers and health workers also expressed concerns related to AEFI. 
The MoH, in coordination with other local partners, should explore strategies for 
augmenting health worker KAPs on vaccine contraindications and policies for catch-up of 
delayed vaccinations. Trainings that include both EPI and non-EPI staff are needed to raise 
awareness about immunization among health workers; such knowledge is expected to have a 
positive spillover effect to caregivers [24].
The researchers also documented systems issues, such as the lack of a working refrigerator 
at one health center that serves a high proportion of the community; limited availability of 
vaccination services on weekends and holidays; and an overall setup and patient flow in 
several health facilities that negatively impacted cross-departmental referrals. Replacing an 
old refrigerator with a functioning refrigerator is a potential quick win in reducing MOV by 
ensuring adequate cold storage for the necessary vaccines. The HNGV offered vaccination 
services only to newborns. Once discharged from the hospital, caregivers had to go to their 
local clinic to vaccinate their children with the remaining antigens in the infant schedule. 
Given that a high proportion of patients from Dili and beyond regularly receive non-
vaccination services at the HNGV, making the necessary national policy changes to enable 
vaccine delivery at the HNGV could significantly improve the immunization status of many 
children, some of whom are referred from distant districts. Additionally, because the high 
proportion of MOV in this study was driven by the lack of vaccination services at the two 
health facilities with the highest patient loads, other districts are expected to have lower 
MOV proportions. The MoH should continue to explore innovate solutions to ameliorate the 
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impact of the policy bottle-neck of not providing vaccination services at the HNGV. Other 
potential strategies for reducing MOV and increasing coverage may include updating 
national policies; improve LISIO ownership and ensure vaccination checks at all visits, 
irrespective of the reason for the visit; reorganize health facilities to provide vaccines; and 
streamline the vaccination and referral processes in the bigger CHCs (such as establishing a 
pre-registration triage and vaccination check-and-refer system).
4.1. Action steps to reduce MOV following the field assessment
The WHO methodology recommends conducting a brainstorming session immediately 
following the field data collection. The brainstorming session in Timor Leste consisted of 
three working groups and brought together the data collectors for the MOV assessment, 
MoH staff members from both immunization and child health departments, and local and 
international partners, to develop an action plan with interventions to reduce MOV based on 
their findings from the field. Following the brainstorming session, the field team led a high-
level national debriefing to endorse the action plan and ensure funding and sustainability of 
the proposed interventions.
Since 2016, Timor Leste has worked to implement many of the interventions outlined in its 
MOV action plan. A desk review conducted in early 2018 by WHO Timor Leste country 
office and WHO Headquarters staff on the status of implementation showed that 65% of the 
proposed interventions had so far been partly or fully implemented within two years of field 
work. The interventions followed a three pronged approach targeting caregivers, health 
workers, and health systems. Non-functional cold chain equipment was promptly replaced 
following the field assessment, and distribution of refrigerators was expedited to health 
centers that did not have them. Timor Leste started regular health promotion and formal 
social mobilization meetings. All CHC and hospital staff members participated in a series of 
trainings on immunization during 2016–2017 that included pre- and post-tests, role playing, 
and practical demonstrations. These health promotion activities were evaluated in late 2017 
for uptake and impact. Dili Municipality has also instituted performance-based incentives 
where best-performing health posts and CHCs in Dili Municipality are rewarded annually.
Additionally, Timor Leste plans to conduct additional trainings to educate health workers on 
the importance of recording vaccine doses in the LISIO and the importance of facilitating 
LISIO ownership among caregivers. Timor Leste also institutionalized monthly supportive 
supervision visits using a newly developed checklist with items specific to MOV. To address 
health systems challenges, Timor Leste implemented a monthly card-based defaulter 
tracking system, relocated the vaccination areas in certain clinics to streamline health center 
flow, and expanded selected CHC hours to include weekend hours.
Timor Leste continues to demonstrate its commitment to immunization activities with 
support from Gavi. Since the assessment in 2016, Timor Leste has capitalized on several 
different types of Gavi support, including a graduation grant and Health Systems 
Strengthening funds, to support the implementation of these MOV interventions. Similarly, 
the MoH plans to scale up successful MOV interventions beyond Dili Municipality, 
especially in the five referral hospitals with high patient volume and minimal vaccination 
services.
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4.2. Study limitations
As stated in the MOV methodology, due to the sampling methodology, this assessment was 
not intended to be nationally representative or representative of the Dili Municipality. As 
such, it should be considered as a program assessment to identify areas of improvement for 
reducing MOV. In addition, while the questionnaires had been piloted and adapted to the 
country-context, there were still areas in which they could have been improved; questions 
may have been indicated as single-response, where a multiple-response option would have 
been more appropriate; also, some response choices lacked clarity, and some responses 
warranted an “other” response option with the option to specify an answer. Similarly, 
although there were efforts to ensure that caregiver exit interviews and focus group 
discussions were conducted away from the earshot of health workers or higher-ups, these 
were conducted within the vicinity of health facilities due to logistical constraints. As a 
result, the responses we received may provide a more favorable view of the health facility 
and quality of services received. Finally, the estimation of MOV was limited to children with 
documented vaccination dates, either from their LISIO or the health center register. We 
would expect children without documentation to be more likely to have had a MOV, so the 
true estimate of MOV in Dili is likely to be higher [13].
5. Conclusion
In a young country like Timor Leste, ensuring that health remains a priority is important for 
building strong and sustainable human and economic capital. Timor Leste was the first 
country in the Southeast Asia Region to implement the updated WHO MOV methodology. 
The MOV assessment has shown that 41% of children eligible for one or more vaccines and 
who visited the health facilities on the day of the assessment had a preventable MOV. In 
Timor Leste, as in other countries, there are several low-hanging fruit opportunities to 
increase the efficiencies of the vaccination programs. Since the MOV assessment, Timor 
Leste has continued to make substantial efforts to strengthen its immunization program 
through implementation of activities to reduce MOV. These activities contributed to the 
country’s recent achievement of verifying the elimination of measles, rubella, and congenital 
rubella syndrome in 2018. Measures to reduce MOV and improve health system efficiencies 
must continue to be scaled up across the country. Furthermore, the use of the updated WHO 
methodology has shown that it is a low resource intensive strategy that is able to provide a 
wide-range of actionable solutions. Other countries in the region could learn from the 
experience of Timor Leste in conducting an assessment of MOV and implementing 
successful interventions. Given the flexibility of the updated methodology, it lends itself 
easily to adaptation to different country contexts.
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Fig. 1. 
Health-center-based flow-chart for determining missed opportunities for vaccination (MOV), 
Timor Leste, 2016. 1All children were without contraindications. 2Missed opportunity for 
vaccination (MOV): contact with health services by a child (or adult) who is eligible for 
vaccination (unvaccinated, partially vaccinated/not up-to-date and free of contraindications 
to vaccination), which does not result in the individual receiving all vaccine doses for which 
he/she is eligible [13–15]
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Table 2
Characteristics of surveyed caregivers of children with documented vaccination dates, Timor Leste, 2016.
n %
286
Child demographics
Sex 275
 Male 142 52
 Female 133 48
Age 286
 <12 months 263 92
 ≥12 months 23 8
Ever vaccinated 259
 Yes 226 87
 No 33 13
Caregiver demographics
Relationship to child 270
 Mother 252 93
 Father 17 6
 Uncle/aunt/grandparent 1 <1
Educational Level 278
 None 23 8
 At least some primary 45 16
 At least some secondary 210 76
Health center visit
Type of Health Center 286
 Public national hospital 35 12
 Public community health center 183 64
 Private or nongovernmental organization health center 68 24
Child has home-based record 271
 Yes, available at this visit 235 87
 Yes, but not available at this visit 35 13
 No 1 <1
Did staff ask for the card? 255
 Yes 187 73
 No 68 27
Knowledge and Attitudes
How would you assess your level of knowledge on vaccines/vaccination? 277
 Adequate 17 6
 Fairly adequate 188 68
 Inadequate 72 26
Ever requested for but refused vaccination services? 273
 Yes 57 21
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n %
286
 No 216 79
Told about vaccination reactions?1 169
 Yes 127 75
 No 42 25
Informed of next vaccination date?1 169
 Yes 155 92
 No 14 8
Satisfied with service today?1 169
 Yes 164 97
 No 5 3
Suggestions for improving health center services2 171
 Less of a wait 45 26
 Hours and days when vaccinations are available should not be limited 24 14
 Friendlier treatment of the public 19 11
 Health centers should always have vaccination materials 19 11
 More personnel should be available 46 27
 Better information should be provided on vaccines given, diseases prevented, and reactions produced 49 29
1Among caregivers who indicated that their child had been vaccinated on the day of the assessment.
2
Respondents allowed to select multiple responses.
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Table 5
Characteristics and knowledge, attitudes, and practices of surveyed health workers, Timor Leste, 2016.
n %
169
Health worker demographics
Sex 165
 Male 34 21
 Female 131 79
Professional Training 162
 Clinician 38 23
 Nurse/Midwife 106 65
 Nursing Assistant 9 6
 Other 9 6
Years of experience 169
 0 to 4 72 43
 5 to 9 40 24
 10 to 14 16 9
 15 to 19 9 5
 20+ 32 19
Type of Service 169
 Public 139 82
 Private 30 18
Ever trained in vaccination or vaccine-preventable diseases 169
 Yes 76 45
 No 93 55
Opportunities for clinical or academic trainings as part of job 168
 Yes 94 56
 No 74 44
Health worker knowledge, attitudes, practices
My knowledge of vaccination and the EPI is sufficient to meet its needs 169
 Agree 114 67
 Disagree 55 33
Contraindications for any vaccine 167
 Local reaction to previous dose 7 4
 Low-grade fever 40 24
 Seizures under medical treatment 33 20
 Pneumonia and other serious diseases 40 24
 None of the above 47 28
When should vaccination status be assessed? 164
 Child’s wellness/routine visit 54 33
 Consultation for any illness 37 23
 When a child is accompanying an adult for any reason 29 18
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n %
169
 All of the above 44 27
Why is vaccination status incomplete for some children? 169
 Parents’ negative beliefs related to vaccination 86 51
 Hours of vaccination are incompatible with parents’ schedule 14 8
 Health workers do not review children’s vaccination cards or vaccination status 9 5
 False contraindications for vaccination by health workers 2 1
 All of the above 58 34
I fear adverse reactions to vaccines 169
 Agree 68 40
 Disagree 101 60
Completing vaccination registers delays vaccination 169
 Agree 77 46
 Disagree 92 54
What instructions do you give caregivers when you give them a new vaccination card?1,2 42
 Keep the card safe 20 48
 Bring this card to all visits to the health center 32 76
 Bring this card only when you come for vaccinations 9 41
 Other 1 4
There is sufficient staff offering immunization services at this center2 42
 Agree 36 86
 Disagree 6 14
There are enough vials of vaccine for all patients in need2 42
 Agree 39 93
 Disagree 3 7
1
Respondents were allowed to select multiple responses.
2Only asked of health workers who administer vaccines as part of their job.
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